Immutep Limited - ADR

:IMMP  
0.31
-0.01 (-2.52%)
7:56:18 PM EDT: $0.31 0.00 (-0.99%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immutep Limited - ADR Stock, :IMMP

Australia Square, 264 George Street, Sydney, New South Wales (NSW) 2000
Australia
Phone: +61.2.8315.7003
Number of Employees:

Description

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK�781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.